Literature DB >> 27861135

Pressure Ulcers in the United States' Inpatient Population From 2008 to 2012: Results of a Retrospective Nationwide Study.

Karen Bauer1, Kathryn Rock2, Munier Nazzal3, Olivia Jones3, Weikai Qu3.   

Abstract

Pressure ulcers are common, increase patient morbidity and mortality, and costly for patients, their families, and the health care system. A retrospective study was conducted to evaluate the impact of pressure ulcers on short-term outcomes in United States inpatient populations and to identify patient characteristics associated with having 1 or more pressure ulcers. The US Nationwide Inpatient Sample (NIS) database was analyzed using the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9 CM) diagnosis codes as the screening tool for all inpatient pressure ulcers recorded from 2008 to 2012. Patient demographics and comorbid conditions, as identified by ICD-9 code, were extracted, along with primary outcomes of length of stay (LOS), total hospital charge (TC), inhospital mortality, and discharge disposition. Continuous variables with normal distribution were expressed in terms of mean and standard deviation. Group comparisons were performed using t-test or ANOVA test. Continuous nonnormal distributed variables such as LOS and TC were expressed in terms of median, and nonparametric tests were used to compare the differences between groups. Categorical data were presented in terms of percentages of the number of cases within each group. Chi-squared tests were used to compare categorical data in different groups. For multivariate analysis, linear regressions (for continuous variable) and logistic regression (for categorical variables) were used to analyze the possible risk factors for the investigated outcomes of LOS, TC, inhospital mortality, and patient disposition. Coefficients were calculated with multivariate regression with all included patients versus patients with pressure ulcers alone. The 5-year average number of admitted patients with at least 1 pressure ulcer was determined to be 670 767 (average overall rate: 1.8%). Statistically significant differences between patients with and without pressure ulcers were observed for median LOS (7 days [mean 11.1 ± 15] compared to 3 days [mean 4.6 ± 6.8]) and median TC ($36 500 [mean $72 000 ± $122 900] compared to $17 200 [mean $32 200 ± $57 500]). The mortality rate in patients with a pressure ulcer was significantly higher than in patients without a pressure ulcer (9.1% versus 1.8%, OR = 5.08, CI: 5.03-5.1, P <0.001). Pressure ulcers were significantly more common in patients who were older or had malnutrition. The results of this study confirm the importance of prevention initiatives to help reduce the negative impact of pressure ulcers on patient outcomes and costs of care.

Entities:  

Mesh:

Year:  2016        PMID: 27861135

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  28 in total

1.  Decubitus ulcers in patients undergoing vascular operations do not influence mortality but affect resource utilization.

Authors:  J Hunter Mehaffey; Amani D Politano; Castigliano M Bhamidipati; Margaret C Tracci; Kenneth J Cherry; John A Kern; Irving L Kron; Gilbert R Upchurch
Journal:  Surgery       Date:  2017-03-18       Impact factor: 3.982

2.  Evaluation of Postoperative Functional Health Status Decline Among Older Adults.

Authors:  Lindsey M Zhang; Melissa A Hornor; Thomas Robinson; Ronnie A Rosenthal; Clifford Y Ko; Marcia M Russell
Journal:  JAMA Surg       Date:  2020-10-01       Impact factor: 14.766

3.  Patient education materials on pressure injury prevention in hospitals and health services in Victoria, Australia: Availability and content analysis.

Authors:  Victoria Team; Ayoub Bouguettaya; Catelyn Richards; Louise Turnour; Angela Jones; Helena Teede; Carolina D Weller
Journal:  Int Wound J       Date:  2019-12-18       Impact factor: 3.315

4.  The national cost of hospital-acquired pressure injuries in the United States.

Authors:  William V Padula; Benjo A Delarmente
Journal:  Int Wound J       Date:  2019-01-28       Impact factor: 3.315

5.  Burden of Pressure Injuries: Findings From the Global Burden of Disease Study.

Authors:  Charalampos Siotos; Andrew M Bonett; George Damoulakis; Adan Z Becerra; George Kokosis; Keith Hood; Amir H Dorafshar; Deana S Shenaq
Journal:  Eplasty       Date:  2022-06-13

6.  Examining the Concordance in the Documented Pressure Injury Site, Stage, and Count in Medical Information Mart for Intensive Care-III.

Authors:  Wenhui Zhang; Mani Sotoodeh; Joyce C Ho; Roy L Simpson; Vicki S Hertzberg
Journal:  Appl Clin Inform       Date:  2021-09-29       Impact factor: 2.762

7.  Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides.

Authors:  Anne Dallas; Artem Trotsyuk; Heini Ilves; Clark A Bonham; Melanie Rodrigues; Karl Engel; Janos A Barrera; Nina Kosaric; Zachary A Stern-Buchbinder; Aleksandr White; Kenneth J Mandell; Paula T Hammond; Jonathan Mansbridge; Sumedha Jayasena; Geoffrey C Gurtner; Brian H Johnston
Journal:  Tissue Eng Part A       Date:  2018-06-29       Impact factor: 3.845

8.  Deep tissue loads in the seated buttocks on an off-loading wheelchair cushion versus air-cell-based and foam cushions: finite element studies.

Authors:  Lea Peko Cohen; Amit Gefen
Journal:  Int Wound J       Date:  2017-09-06       Impact factor: 3.315

9.  Predicting pressure injury using nursing assessment phenotypes and machine learning methods.

Authors:  Wenyu Song; Min-Jeoung Kang; Linying Zhang; Wonkyung Jung; Jiyoun Song; David W Bates; Patricia C Dykes
Journal:  J Am Med Inform Assoc       Date:  2021-03-18       Impact factor: 4.497

10.  Hospital-Acquired Pressure Injury Development Among Surgical Critical Care Patients Admitted With Community-Acquired Pressure Injury: A Retrospective Cohort Study.

Authors:  Jenny Alderden; Mollie Cummins; Sunniva Zaratkiewicz; Yunchuan 'Lucy' Zhao; Kathryn Drake; Tracey L Yap
Journal:  J Wound Ostomy Continence Nurs       Date:  2020 Sep/Oct       Impact factor: 1.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.